the aid library

LIST OPTIONS

Filter

10718

Community-based health care, including outreach and campaigns,in the context of the COVID-19 pandemic
recommended

World Health Organization WHO, IFRC; UNICEF (2020) C_WHO

The COVID-19 pandemic is challenging health systems across the world. Rapidly increasing demand for care of people with COVID-19 is compounded by fear, misinformation and limitations on the movement of people and supplies that disrupt the delivery of frontline health care for all people... This g... more

Effective Implementation of Public Health and Social Measures in Egypt: Situational Analysis

WHO; Africa CDC; World Economic Forum et al. PERC (2020) C_WHO

PERC produces regional and member state situation analyses, updated regularly.

Effective Implementation of Public Health and Social Measures in Mozambique: Situational Analysis

WHO; Africa CDC; World Economic Forum et al. PERC (2020) C_WHO

PERC produces regional and member state situation analyses, updated regularly.

Download (86)

View PDF (121)

Effective Implementation of Public Health and Social Measures in Tanzania: Situational Analysis

WHO; Africa CDC; World Economic Forum et al. PERC (2020) C_WHO

PERC produces regional and member state situation analyses, updated regularly.

Download (91)

View PDF (115)

Smoking and COVID-19

World Health Organization WHO (2020) C_WHO

Scientific Brief, 30 June 2020

Download (390)

View PDF (239)

Manual on community-based mental health and psychosocial support in emergencies and displacement

International Organization for Migration IOM (2020) C1

Download (101)

View PDF (126)

Moldova: COVID-19 - Socio-Economic Response and Recovery Plan – June 2020

United Nations in Moldova (2020) C1

Download (144)

View PDF (184)

COVID-19 pandemic in the health of women, children, and adolescents in Latin America and the Caribbean

Castro, A. UNDP (2020) CC

Download (128)

View PDF (138)

Setup and management of COVID-19 hotlines

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

Syrian Public Health after COVID-19: Entry Points and Lessons Learned from the Pan

Center for Operational Analysis and Research COAR (2021) CC

March 2021

Regional guide for determining health workforce staffing norms and standards for health facilities

WHO Universal Health CoverageLife Course Cluster, WHO Regional Office WHO Regional Office for Africa (2021) C_WHO

Download (162)

View PDF (235)

National agrifood systems and COVID-19 in South Sudan: Effects, policy responses, and long-term implications

Food and Agriculture Organization of the United Nations FAO (2022) C1

The COVID-19 pandemic has put significant pressure on health systems all around the world. The drastic measures established to contain its spread are creating serious impediments to economic activity (including agrifood systems) and, consequently, to livelihoods and food security and nutrition.

Consolidated report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services

World Health Organization WHO (2022) C_WHO

20 April 2022. The response to the COVID-19 pandemic continues to adversely affect essential TB services in many countries. A first report of case studies was published in 2021 comprising 23 examples of innovative interventions implemented by countries to effectively respond to disruptions of TB ser... more

Download (137)

View PDF (158)

Guidance and tool for countries to identify priority areas for intervention

World Health Organization WHO Global Task Force on Cholera (2019) C_WHO

This document aims to provide guidance to countries in the identification of priority areas for intervention as part of the Situational Analysis of their National Cholera Control or Elimination Plans (NCPs).

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (182)

View PDF (253)

WHO QualityRights Tool Kit Assessing and improving quality and human rights in mental health and social care facilities

World Health Organization WHO WHO (2012) C_WHO

The aim of the WHO QualityRights tool kit is to support countries in assessing and improving the quality and human rights of their mental health and social care facilities. The tool kit is based on an extensive international review by people with mental disabilities and their organizations. It ha... more